Chemical Structure (Levetiracetam Solution 1)
Levetiracetam
Product Images NDC 81646-116
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 81646-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pinnacle Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Levetiracetam Solution 2)
This is a chart that shows the percentage of patients in a study who experienced certain outcomes with different doses of Levetiracetam and Placebo. The outcomes are not specified in the given text.*
Figure 2 (Levetiracetam Solution 3)
This appears to be a table displaying percentages of patients in a clinical trial. The trial involved a placebo group and a group taking the drug Levetiracetam at a dosage of 1000mg per day. However, without more information, it is unclear what the percentages are representing.*
Figure 3 (Levetiracetam Solution 4)
This text displays the percentage of patients in a clinical trial who were given a placebo and levetiracetam 3000 ma/dav. The numbers listed are 14.4% and 39.4%, but the context of what these percentages refer to is not provided.*
Figure 4 (Levetiracetam Solution 5)
Figure 5 (Levetiracetam Solution 6)
This appears to be a table showing the percentage of patients in two different groups, one group receiving a drug called Levetracetum and the other receiving a placebo (N= sample size). The table indicates that 43.1% of patients in the Levetracetum group had some sort of statistic significance versus the 19.6% in the placebo group. However, there isn't sufficient information available to interpret the meaning of the 0.9% labeled as 'g%' or any other context.*
Figure 6 (Levetiracetam Solution 7)
This appears to be a chart showing the percentage of patients who achieved a certain outcome for a study comparing placebo to levetiracetam. The outcomes are not specified in the given text.*
Cup Label (Levetiracetam Solution 8)
This is an oral solution medication called Levetiracetam with a strength of 500 mg per 5 ml. It is only available with a prescription. The bottle contains 5 ml of the solution and has an expiration date of April 2021. The UDS lot number is 123456 and it was manufactured by Pharma. The Hig and Hig Lok numbers provided are not clear and their meaning is not clear.*
Box Label (Levetiracetam Solution 9)
This is a description of a medication named Levetiracetam which is an oral solution. Each 5 ml contains 500mg/5ml of Levetiracetam. The package insert should be checked for indications and dosage schedule. The medication should be stored at a controlled room temperature between 20 to 25 Celsius. The drug should be kept out of reach of children. Lot 123458 of the medication has an expiration date of MMIDDIYYYY. The medication is distributed by Pinacle Pravma LLG and the product quantity is 72 cups.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
